Form 4: Amneal Pharmaceuticals Executive Sells 13,665 Shares

Amneal Pharmaceuticals' SVP, Chief Legal Officer, Jason B. Daly, sold 13,665 shares of Class A Common Stock at $8.40 per share on November 21, 2024.

Summary

• Jason B. Daly, the SVP and Chief Legal Officer of Amneal Pharmaceuticals, sold 13,665 shares of Class A Common Stock.
• The transaction occurred on November 21, 2024.
• The sale price was $8.40 per share.
• The shares were sold directly by Mr. Daly.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common when company executives trade shares. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale by Jason B. Daly is similar to other executive stock sales reported across the pharmaceutical industry.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Amneal Pharmaceuticals, insider trading, stock sale, executive, AMRX, Class A Common Stock